Teduglutide
Also known as: Gattex, Revestive, GLP-2 Analog
GLP-2 analog promoting intestinal mucosal growth and repair; increases villus height and crypt depth for nutrient absorption.
- Typical dose
- 3.5 mg
- Frequency
- once daily
- Route
- Subcutaneous
- Half-life
- 2 hours
- Routes
- Subcutaneous
- Status
- FDA-approved for short bowel syndrome
Benefits
- Intestinal rehabilitation
- Reduces IV nutrition dependence
- Mucosal repair
- Nutrient absorption improvement
Dosing
A common research range for Teduglutide is 3.5 mg once daily. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Reconstitution
A typical reconstitution for Teduglutide is 5 mg of peptide in 0.5 mL of bacteriostatic water, giving roughly 10 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.
Half-life
Teduglutide has an approximate half-life of 2 hours. Vial can display informational half-life estimates when supported data is available. These estimates are not measured blood concentrations or dosing instructions.
Storage
2-8°C; use within 3 hours of reconstitution.
Reported side effects
- Abdominal pain
- Nausea
- Injection site reactions
- Intestinal polyps (monitor)
Contraindications
- Active GI malignancy
- History of GI cancer within 5 years
Track Teduglutide with Vial
Vial logs every Teduglutide dose, organizes your schedule, and offers reconstitution math and supported half-life estimates. Tracking records stay on your device. A Vial Pro subscription is required. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. Teduglutide is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.